Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xlear Sinus Care is a natural nasal and sinus care product line developed by Xlear, Inc. The formulation consists of xylitol, a natural five-carbon sugar alcohol, combined with a saline (sodium chloride) solution. Unlike traditional pharmaceutical decongestants, Xlear works through a mechanical mechanism of action: xylitol acts as a moisturizing and cleansing agent that inhibits the adhesion of bacteria and other contaminants to nasal tissues while pulling moisture to the cell surface. It is indicated for the relief of nasal congestion, dry sinuses, allergies, and sinusitis, and is used for general nasal hygiene. The product line includes nasal sprays and sinus rinse systems and is classified as a drug-free medical device or wellness product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xlear Sinus Care.